News|Articles|October 8, 2015

PaizaBio Introduces Aseptic Services for China Market

Contract manufacturer PiazaBio announces services for Western Pharma companies seeking to enter the China market.

PaizaBio, a contract manufacturer and marketing agent based in Albuquerque, NM, USA, has announced sterile injectable services for Western pharmaceutical companies seeking entry into China’s market.

PaizaBio reports in a company announcement that it has implemented processes and services to ensure quality, competitiveness, and transparency in China, including a training program for a qualified aseptic workforce; a digital and video production monitoring system; and lyophilization services.

The company’s manufacturing presence in China includes a 40,000-square-meter compound, encompassing a 25,000-square-meter production facility and 10,000-square-meter warehouse. Production equipment includes nine automated filling lines for vials, cartridges and syringes; 10 capping lines; a packaging facility with automated and manual options; four formulation tanks with a capacity of 3,000 liters; and laboratory facilities for testing, validation, analysis, and development. Additionally, the company offers clients expertise in Chinese regulatory compliance.

Soource: PaizaBio

 


Related to this article

Ask the Expert: Choosing Ingredient Suppliers
Jane Zhang of ETCH Sourcing explains why geopolitics, transparency, and partnership now weigh as heavily as cost and quality when companies choose suppliers, in this episode of Ask the Expert, moderated by Susan J. Schniepp of Nelson Labs.